glp-1 drugs and fatty liver Receptor Agonist Non-Alcoholic Disease GLP1 Therapy Gains Traction Treating

Exploring the potential of astrocytes as therapeutic targets for neurodegenerative disorders What therapeutic benefits can healthy astrocytes offer in AD

Tonum publishes trial summaries and resources that explain how different oral and prescription options compare

Information-dependent data acquisition mode was used to switch automatically between MS and MS/MS acquisition with the following parameters: an ion spray voltage of 2,500 V, curtain gas (CUR) of 25 p

For peptides like ipamorelin and CJC-1295, the most valuable thing a clinician can learn is how to reason about them honestly : how to read the strength and limits of the evidence, how to interpret regulatory status, how to evaluate sourcing, and how to communicate uncertainty to patients without overpromising

You are pregnant or breastfeeding without first discussing risks and benefits with your healthcare provider